logo

For the Inventor, By the Inventor

Winston-Salem, NC, United States of America

Targacept, Inc.


USPTO Granted Patents = 91

% Expired Patents = 56.0



Forward Citations = 773

Loading Chart...
Loading Chart...

78 inventors (with patents filed for the assignee):

goldMedal Gary Maurice Dull (45 out of 87 patents)

silverMedal Balwinder Singh Bhatti (33 out of 43 patents)

bronzeMedal Craig Harrison Miller (30 out of 37 patents)

4.  Anatoly A Mazurov (23 out of 26 patents)

5.  Lan Miao (22 out of 24 patents)

6.  Jeffrey Daniel Schmitt (22 out of 24 patents)

7.  William Scott Caldwell (20 out of 49 patents)

8.  Merouane Bencherif (16 out of 33 patents)

9.  Julio A Munoz (14 out of 20 patents)

10.  Jared Miller Wagner (12 out of 16 patents)

11.  Peter Anthony Crooks (11 out of 97 patents)

12.  Srishailkumar Basawannappa Hadimani (10 out of 11 patents)

13.  Teresa Phillips (9 out of 9 patents)

14.  Jozef Klucik (9 out of 10 patents)

15.  John Genus (8 out of 8 patents)


Core Competencies:
Nicotinic Antagonists
Cholinergic Receptors
Pharmaceutical Compositions
CNS Disorders
Aryl Substituted Compounds
Salt Forms
Diazabicycloalkanes
Hydroxybenzoate Salts
Combination Therapy
Neuronal Ligands
Pain Relief
Cognitive Deficits

91 patents:

1. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),
2. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine (2015-09-29),
3. 9107915 - Hydroxybenzoate salts of metanicotine compounds (2015-08-18),
4. 8921410 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-12-30),
5. 8901177 - Method of treating bladder disorders (2014-12-02),
6. 8901151 - Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide (2014-12-02),
7. 8859609 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-10-14),
8. 8846715 - (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof (2014-09-30),
9. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),
10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),
11. 8778978 - Hydroxybenzoate salts of metanicotine compounds (2014-07-15),
12. 8703802 - Process for the preparation of aryl substituted olefinic amines (2014-04-22),
13. 8633227 - Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine (2014-01-21),
14. 8633222 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2014-01-21),
15. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine (2013-12-10),
Targacept, Inc. is a biopharmaceutical company based in Winston-Salem, North Carolina, specializing in the development of innovative therapies targeting cholinergic receptors. The company focuses on nicotinic antagonists and their applications in treating central nervous system disorders. Targacept's research encompasses a range of advanced pharmaceutical compositions, including aryl substituted compounds and various salt forms, aimed at addressing unmet medical needs in neurological health.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

91 Patents

#9 in Winston-Salem, NC

#103 in North Carolina

#4,103 in US

#8,429 in the World

Winston-Salem, NC (US)
Winston-Salem, NC, United States of America

Targacept, Inc.

Forward Citations = 773

78 inventors:

goldMedal Gary Maurice Dull (45 out of 87 patents)

silverMedal Balwinder Singh Bhatti (33 out of 43 patents)

bronzeMedal Craig Harrison Miller (30 out of 37 patents)

4.  Anatoly A Mazurov (23 out of 26 patents)

5.  Lan Miao (22 out of 24 patents)

Please report any incorrect information to [email protected]
Loading…